Dogwood Therapeutics, Inc. Variable Lease, Cost
Dogwood Therapeutics, Inc. (DWTX) reported Variable Lease, Cost of $13.40 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-14
- Dogwood Therapeutics, Inc. variable lease, cost for the quarter ending 2026-06-30 was $13.40K, a 52.40% increase year-over-year.
- Dogwood Therapeutics, Inc. variable lease, cost for the quarter ending 2026-03-31 was $13.53K, a 0.93% decline year-over-year.
- Dogwood Therapeutics, Inc. variable lease, cost for the quarter ending 2025-12-31 was $14.05K.
- Dogwood Therapeutics, Inc. variable lease, cost for the quarter ending 2025-09-30 was $14.23K.
- Dogwood Therapeutics, Inc. variable lease, cost for fiscal 2025 was $50.73K, a 258.06% increase from fiscal 2024.
- Dogwood Therapeutics, Inc. variable lease, cost for fiscal 2024 was $14.17K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.40K 10-Q · filed 2026-08-14 | $26.93K 10-Q · filed 2026-08-14 | $40.98K derived: sum of 3 quarters · filed 2026-08-14 | $55.21K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $13.53K 10-Q · filed 2026-05-15 | $27.58K derived: sum of 2 quarters · filed 2026-05-15 | $41.81K derived: sum of 3 quarters · filed 2026-05-15 | $50.60K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $14.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $28.28K derived: sum of 2 quarters · filed 2026-03-18 | $37.07K derived: sum of 3 quarters · filed 2026-08-14 | $50.73K 10-K · filed 2026-03-18 |
| 2025-09-30 | $14.23K 10-Q · filed 2025-11-07 | $23.02K derived: sum of 2 quarters · filed 2026-08-14 | $36.68K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $8.79K 10-Q · filed 2026-08-14 | $22.45K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $13.65K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $14.17K 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |